Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients

ALS remains a fatal, neurodegenerative motor neuron disease. Numerous studies seem to confirm that innate immune system is involved in the pathophysiology of ALS. Hence, the assessment of the complement system and attempts to modify its activity remain the target of medical intervention in ALS. In t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anna Sobuś, Bartłomiej Baumert, Monika Gołąb-Janowska, Piotr Kulig, Edyta Paczkowska, Karolina Łuczkowska, Dorota Rogińska, Alicja Zawiślak, Sławomir Milczarek, Bogumiła Osękowska, Wioletta Pawlukowska, Agnieszka Meller, Karolina Machowska-Sempruch, Agnieszka Wełnicka, Przemysław Nowacki, Bogusław Machaliński
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
amyotrophic lateral sclerosis
lineage-negative cells
cell therapy
innate immunity
complement system
Medicine
R
Accès en ligne:https://doaj.org/article/b0ad234936694f92a088923edad79b3e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b0ad234936694f92a088923edad79b3e

Documents similaires